A. C. Mehta

609 total citations
40 papers, 443 citations indexed

About

A. C. Mehta is a scholar working on Spectroscopy, Analytical Chemistry and Biomedical Engineering. According to data from OpenAlex, A. C. Mehta has authored 40 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Spectroscopy, 14 papers in Analytical Chemistry and 7 papers in Biomedical Engineering. Recurrent topics in A. C. Mehta's work include Analytical Chemistry and Chromatography (15 papers), Analytical Methods in Pharmaceuticals (14 papers) and Microfluidic and Capillary Electrophoresis Applications (6 papers). A. C. Mehta is often cited by papers focused on Analytical Chemistry and Chromatography (15 papers), Analytical Methods in Pharmaceuticals (14 papers) and Microfluidic and Capillary Electrophoresis Applications (6 papers). A. C. Mehta collaborates with scholars based in United Kingdom, United States and India. A. C. Mehta's co-authors include Robert Calvert, M. Feely, K.S. Ryatt, BK Park, J.A. COTTERILL, Alistair Hay, Layla Bradford, J. W. Feather, John P. Cooke and J. B. Dawson and has published in prestigious journals such as The Lancet, Journal of Pharmaceutical Sciences and TrAC Trends in Analytical Chemistry.

In The Last Decade

A. C. Mehta

39 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. C. Mehta United Kingdom 14 156 124 70 58 46 40 443
H Jaeger Germany 13 126 0.8× 126 1.0× 102 1.5× 56 1.0× 37 0.8× 58 487
R.R. Brodie United States 15 110 0.7× 135 1.1× 84 1.2× 26 0.4× 45 1.0× 42 570
Clark March United States 9 82 0.5× 96 0.8× 78 1.1× 46 0.8× 29 0.6× 18 364
M. A. F. Gadalla United States 9 123 0.8× 112 0.9× 151 2.2× 28 0.5× 40 0.9× 15 334
P. V. Macrae United Kingdom 11 197 1.3× 205 1.7× 118 1.7× 51 0.9× 53 1.2× 16 618
P. Haefelfinger Switzerland 10 120 0.8× 114 0.9× 135 1.9× 28 0.5× 29 0.6× 28 375
P. J. M. Guelen Netherlands 14 77 0.5× 111 0.9× 183 2.6× 25 0.4× 65 1.4× 40 581
Ching‐Ling Cheng Taiwan 9 65 0.4× 104 0.8× 70 1.0× 19 0.3× 55 1.2× 12 439
Adnan El‐Yazigi Saudi Arabia 15 73 0.5× 72 0.6× 110 1.6× 26 0.4× 64 1.4× 60 597
E. Bossù Italy 11 106 0.7× 67 0.5× 69 1.0× 57 1.0× 19 0.4× 28 370

Countries citing papers authored by A. C. Mehta

Since Specialization
Citations

This map shows the geographic impact of A. C. Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. C. Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. C. Mehta more than expected).

Fields of papers citing papers by A. C. Mehta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. C. Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. C. Mehta. The network helps show where A. C. Mehta may publish in the future.

Co-authorship network of co-authors of A. C. Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of A. C. Mehta. A scholar is included among the top collaborators of A. C. Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. C. Mehta. A. C. Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mehta, A. C., et al.. (1995). In vitro dissolution studies on nifedipine capsules. Journal of Clinical Pharmacy and Therapeutics. 20(4). 243–245. 4 indexed citations
2.
Mehta, A. C.. (1995). Analytical issues in the chemical stability testing of drugs in solution. Analytical Proceedings. 32(2). 67–67. 4 indexed citations
3.
Mehta, A. C., et al.. (1994). Stability of amoxycillin and potassium clavulanate in co-amoxiclav oral suspension. Journal of Clinical Pharmacy and Therapeutics. 19(5). 313–315. 12 indexed citations
4.
Mehta, A. C., et al.. (1994). In vitro dissolution of piroxicam capsules. Journal of Clinical Pharmacy and Therapeutics. 19(1). 37–39. 1 indexed citations
5.
Mehta, A. C.. (1992). A critical appraisal of chromatographic and immunoassay techniques for clinical drug analysis. Journal of Clinical Pharmacy and Therapeutics. 17(6). 325–331. 4 indexed citations
6.
Mehta, A. C., et al.. (1992). High-performance liquid chromatographic determination of ciprofloxacin in plasma. Journal of Clinical Pharmacy and Therapeutics. 17(2). 117–120. 15 indexed citations
7.
Mehta, A. C.. (1990). CHIRAL HIGH PERFORMANCE LIQUID CHROMATOGRAPHY OF DRUG MOLECULES. Journal of Clinical Pharmacy and Therapeutics. 15(5). 313–323. 4 indexed citations
8.
Mehta, A. C., et al.. (1989). Measurement of low (sub-therapeutic) phenobarbitone levels in plasma by high-performance liquid chromatography: application to patient compliance studies. Journal of Chromatography B Biomedical Sciences and Applications. 497. 308–312. 7 indexed citations
9.
Mehta, A. C.. (1989). Potential of wide bore open tubular columns in gas chromatographic analysis of drugs. Journal of Chromatography B Biomedical Sciences and Applications. 494. 1–11. 1 indexed citations
10.
Mehta, A. C.. (1989). THE VALIDATION CRITERIA FOR ANALYTICAL METHODS USED IN PHARMACY PRACTICE RESEARCH. Journal of Clinical Pharmacy and Therapeutics. 14(6). 465–473. 33 indexed citations
11.
Mehta, A. C.. (1988). Direct separation of drug enantiomers by high-performance liquid chromatography with chiral stationary phases. Journal of Chromatography B Biomedical Sciences and Applications. 426(1). 1–13. 52 indexed citations
12.
Pearcey, R., Robert Calvert, & A. C. Mehta. (1988). Disposition of ifosfamide in patients receiving ifosfamide infusion therapy for the treatment of cervical carcinoma. Cancer Chemotherapy and Pharmacology. 22(4). 353–5. 11 indexed citations
13.
Mehta, A. C.. (1987). Pharmacokinetics and the analytical chemist. Talanta. 34(3). 355–360. 2 indexed citations
14.
Mehta, A. C.. (1987). Drug determination in biological fluids—approaches to method validation. Talanta. 34(7). 609–613. 13 indexed citations
15.
Mehta, A. C. & Robert Calvert. (1987). Determination of ifosfamide in plasma by gas chromatography with nitrogen detector. Journal of Chromatography B Biomedical Sciences and Applications. 421(2). 377–380. 14 indexed citations
16.
Mehta, A. C.. (1986). Sample pretreatment in the trace determination of drugs in biological fluids. Talanta. 33(1). 67–73. 15 indexed citations
17.
Mehta, A. C., et al.. (1986). The effect of low‐dose phenobarbitone on three indices of hepatic microsomal enzyme induction.. British Journal of Clinical Pharmacology. 22(6). 744–747. 25 indexed citations
18.
Feely, M., et al.. (1984). Use of Low-Dose Phenobarbitone to Assess Patient Compliance. Clinical Science. 67(s9). 28P–28P. 1 indexed citations
19.
Ryatt, K.S., J.A. Cotterill, & A. C. Mehta. (1983). THE EFFECT OF SERIAL DILUTION OF BETAMETHASONE-17-VALERATE ON BLANCHING POTENTIAL AND CHEMICAL STABILITY. Journal of Clinical Pharmacy and Therapeutics. 8(2). 143–145. 6 indexed citations
20.
Mehta, A. C. & Robert Calvert. (1983). An Improved High-Performance Liquid Chromatographic Procedure for Monitoring Indomethacin in Neonates. Therapeutic Drug Monitoring. 5(1). 143–145. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026